Initial Treatment With Bevacizumab in Choroidal Neovascularization Associated to High Myopia — BENEMCOR  

Choroidal Subfoveal/Juxtafoveal Neovascularization in High Myopia Clinical Trial

Official title: Establishment of the Initial Protocol With Intravitreal Bevacizumab for the Treatment of Choroidal Neovascularization Associated With High Myopia:3 vs 1.

Status Completed

Clinical Trial Summary

The purpose of this protocol is to determine wether the initial protocol in the treatment of subfoveal choroidal neovascularization associated to High Myopia with bevacizumab intravitreal injections is more effective when using 3 doses vs using 1 single dose in the load period

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Choroidal Neovascularization
• Choroidal Subfoveal/Juxtafoveal Neovascularization in High Myopia
• Myopia
• Neovascularization, Pathologic

• NCT number: NCT01716026
• Study type: Interventional
• Source: Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA
• Status: Completed
• Phase: Phase 3
• Start date: October 2012
• Completion date: April 2018